16,018 XNAS Volume
XNAS 28 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| James Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 14,762 | 36,488 | - | 0 | Common Stock | |
| Jodi Devlin | Chief of Clinical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 5,272 | 33,397 | - | 0 | Common Stock | |
| Jennifer Stevens | CHIEF REGULATORY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 14,481 | 57,889 | - | 0 | Common Stock | |
| Bryan F. Cox | CHIEF OF RESEARCH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 11,450 | 108,457 | - | 0 | Common Stock | |
| Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 7,644 | 54,270 | - | 0 | Common Stock | |
| Sean E. Murphy | Director, Chief Manuf, Strategy&Bus Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 15,817 | 79,105 | - | 0 | Common Stock | |
| Mary T. Szela | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 21,089 | 465,348 | - | 0 | Common Stock | |
| David J. Matlin | Director | Other type of transaction at price $ 0.00 per share. | 10 Feb 2025 | 89,501 | 189,501 | - | - | Series A Preferred Stock | |
| Mats L. Wahlstrom | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Feb 2025 | 44,750 | 94,750 | - | - | Series A Convertible Preferred Stock | |
| James Young | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 5.65 per share. | 05 Feb 2025 | 6,000 | 30,000 | - | 5.7 | 33,900 | Common Stock |
| William Valle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 35,000 | 35,000 | - | - | Director Stock Option (right to buy) | |
| William Valle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 6,250 | 6,250 | - | - | Director Stock Option (right to buy) | |
| Mary T. Szela | Director, CEO AND PRESIDENT | Purchase of securities on an exchange or from another person at price $ 5.28 per share. | 29 Jan 2025 | 5,010 | 444,259 | - | 5.3 | 26,453 | Common Stock |
| Mary T. Szela | Director, CEO AND PRESIDENT | Purchase of securities on an exchange or from another person at price $ 5.03 per share. | 29 Jan 2025 | 5,030 | 439,249 | - | 5.0 | 25,301 | Common Stock |
| Bryan F. Cox | CHIEF OF RESEARCH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 10,625 | 97,007 | - | 0 | Common Stock | |
| Mary T. Szela | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 40,000 | 424,677 | - | 0 | Common Stock | |
| Mary T. Szela | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 240,000 | 240,000 | - | - | Employee Stock Option (right to buy) | |
| Mary T. Szela | Director, CEO AND PRESIDENT | Purchase of securities on an exchange or from another person at price $ 5.12 per share. | 27 Jan 2025 | 4,716 | 434,219 | - | 5.1 | 24,146 | Common Stock |
| Mary T. Szela | Director, CEO AND PRESIDENT | Purchase of securities on an exchange or from another person at price $ 5.42 per share. | 27 Jan 2025 | 4,826 | 429,503 | - | 5.4 | 26,157 | Common Stock |
| Sean E. Murphy | Director, Chief Manuf, Strategy&Bus Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 12,500 | 63,288 | - | 0 | Common Stock | |
| Sean E. Murphy | Director, Chief Manuf, Strategy&Bus Dev. | Purchase of securities on an exchange or from another person at price $ 5.31 per share. | 27 Jan 2025 | 15,000 | 182,732 | - | 5.3 | 79,650 | Common Stock |
| Sean E. Murphy | Director, Chief Manuf, Strategy&Bus Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Sean E. Murphy | Director, Chief Manuf, Strategy&Bus Dev. | Purchase of securities on an exchange or from another person at price $ 5.17 per share. | 27 Jan 2025 | 15,000 | 197,732 | - | 5.2 | 77,550 | Common Stock |
| Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 12,500 | 46,626 | - | 0 | Common Stock | |
| Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Bryan F. Cox | CHIEF OF RESEARCH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 63,750 | 63,750 | - | - | Employee Stock Option (right to buy) | |
| Jennifer Stevens | CHIEF REGULATORY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 10,625 | 43,408 | - | 0 | Common Stock | |
| Jennifer Stevens | CHIEF REGULATORY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 63,750 | 63,750 | - | - | Employee Stock Option (right to buy) | |
| Jodi Devlin | Chief of COMMERC. OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 10,625 | 28,125 | - | 0 | Common Stock | |
| Jodi Devlin | Chief of COMMERC. OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 63,750 | 63,750 | - | - | Employee Stock Option (right to buy) | |
| James Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| James Young | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 5.40 per share. | 27 Jan 2025 | 24,000 | 24,000 | - | 5.4 | 129,600 | Common Stock |
| James Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 12,500 | 21,726 | - | 0 | Common Stock | |
| Liselotte Hyveled | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 10,040 | 10,040 | - | 0 | Common Stock | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 10,040 | 941,944 | - | 0 | Common Stock | |
| Mats L. Wahlstrom | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 3.97 per share. | 17 Dec 2024 | 25,188 | 40,915 | - | 4.0 | 99,996 | Common Stock |
| Arjun Desai JJ | Director | Sale of securities on an exchange or to another person at price $ 3.69 per share. | 10 Dec 2024 | 30,000 | 247,127 | - | 3.7 | 110,700 | Common Stock |
| Mats L. Wahlstrom | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.55 per share. | 22 Nov 2024 | 5,000 | 15,727 | - | 4.6 | 22,750 | Common Stock |
| Mats L. Wahlstrom | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.16 per share. | 20 Nov 2024 | 2,040 | 2,040 | - | 4.2 | 8,486 | Common Stock |
| Mats L. Wahlstrom | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.44 per share. | 20 Nov 2024 | 8,687 | 10,727 | - | 4.4 | 38,570 | Common Stock |
| Richard Marshak | SR.VP, CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 41,250 | 41,250 | - | - | Employee Stock Option (right to buy) | |
| Richard Marshak | SR.VP, CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 6,875 | 34,126 | - | 0 | Common Stock | |
| Bryan F. Cox | CHIEF SCIENTIFIC & MANUFACT. | Sale of securities on an exchange or to another person at price $ 4.44 per share. | 05 Oct 2024 | 314 | 86,382 | - | 4.4 | 1,394 | Common Stock |
| Mary T. Szela | Director, CEO AND PRESIDENT | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 Sep 2024 | 6,000 | 384,677 | - | 5 | 30,000 | Common Stock |
| Mary T. Szela | Director, CEO AND PRESIDENT | Purchase of securities on an exchange or from another person at price $ 4.83 per share. | 12 Sep 2024 | 1,295 | 378,677 | - | 4.8 | 6,255 | Common Stock |
| Mary T. Szela | Director, CEO AND PRESIDENT | Purchase of securities on an exchange or from another person at price $ 5.20 per share. | 12 Sep 2024 | 7,520 | 377,382 | - | 5.2 | 39,104 | Common Stock |
| Mary T. Szela | Director, CEO AND PRESIDENT | Purchase of securities on an exchange or from another person at price $ 4.97 per share. | 10 Sep 2024 | 5,000 | 369,862 | - | 5.0 | 24,850 | Common Stock |
| George Kelly Martin | Director | Sale of securities on an exchange or to another person at price $ 5.56 per share. | 28 Aug 2024 | 9 | 247,176 | - | 5.6 | 50 | Common Stock |
| George Kelly Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| Anil K. Singhal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| Arjun JJ Desai | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| Liselotte Hyveled | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| Andrew C. von Eschenbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| Mats L. Wahlstrom | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| Kerry R. Hicks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| Arjun JJ Desai | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 74,000 | 277,127 | - | - | Common Stock | |
| Arjun JJ Desai | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2024 | 246,667 | 0 | - | - | Redeemable Warrants | |
| Andrew C. von Eschenbach | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| Andrew C. von Eschenbach | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Liselotte Hyveled | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Szela Mary T. | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 288,750 | 288,750 | - | - | Employee Stock Option (right to buy) | |
| Mary Szela T. | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 84,899 | 364,862 | - | 0 | Common Stock | |
| Jennifer Stevens | CHIEF REGULATORY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 63,750 | 63,750 | - | - | Employee Stock Option (right to buy) | |
| Jodi Devlin | PRESIDENT, COMMERC. OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 17,500 | 17,500 | - | 0 | Common Stock | |
| Jennifer Stevens | CHIEF REGULATORY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 14,752 | 32,783 | - | 0 | Common Stock | |
| Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 63,750 | 63,750 | - | - | Employee Stock Option (right to buy) | |
| Sean Murphy E. | Director, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 34,144 | 50,788 | - | 0 | Common Stock | |
| Steven C. Katz | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 34,144 | 68,587 | - | 0 | Common Stock | |
| Bryan Cox F. | CHIEF SCIENTIFIC & MANUFACT. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 63,750 | 63,750 | - | - | Employee Stock Option (right to buy) | |
| E. Murphy Sean | Director, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 105,000 | 105,000 | - | - | Employee Stock Option (right to buy) | |
| Katz Steven C. | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 105,000 | 105,000 | - | - | Employee Stock Option (right to buy) | |
| Jodi Devlin | PRESIDENT, COMMERC. OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 105,000 | 105,000 | - | - | Employee Stock Option (right to buy) | |
| Richard Marshak | SR.VP, CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 14,752 | 27,251 | - | 0 | Common Stock | |
| Cox F. Bryan | CHIEF SCIENTIFIC & MANUFACT. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 14,752 | 86,696 | - | 0 | Common Stock | |
| Murphy Sean E. | Director, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) | |
| Jodi Devlin | President, Therapeutics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2023 | 195,000 | 195,000 | - | - | Employee Stock Option (right to buy) | |
| Mary T. Szela | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 172,500 | 172,500 | - | - | Employee Stock Option (right to buy) | |
| Sean E. Murphy | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 62,500 | 62,500 | - | - | Employee Stock Option (right to buy) | |
| Richard Marshak | Sr.VP, Corp. Dev. & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) | |
| Steven C. Katz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 62,500 | 62,500 | - | - | Employee Stock Option (right to buy) | |
| Bryan F. Cox | Chief Scientific & Manufact. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) | |
| Jennifer Stevens | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) | |
| Anil K. Singhal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Mats L. Wahlstrom | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Arjun JJ Desai | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 100,000 | 100,000 | - | - | Series A Preferred Stock | |
| George Kelly Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Kerry R. Hicks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Andrew C. von Eschenbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| David J. Matlin | Director | Other type of transaction at price $ 0.00 per share. | 10 Aug 2023 | 931,904 | 931,904 | - | - | Common Stock | |
| David J. Matlin | Director | Other type of transaction at price $ 0.00 per share. | 10 Aug 2023 | 1,240,518 | 1,240,518 | - | - | Redeemable Warrants | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 35,000 | 35,000 | - | - | Stock Option (right to buy) |